DE2656333C2 - Process for the production of liposomes which contain medicinal substances - Google Patents
Process for the production of liposomes which contain medicinal substancesInfo
- Publication number
- DE2656333C2 DE2656333C2 DE19762656333 DE2656333A DE2656333C2 DE 2656333 C2 DE2656333 C2 DE 2656333C2 DE 19762656333 DE19762656333 DE 19762656333 DE 2656333 A DE2656333 A DE 2656333A DE 2656333 C2 DE2656333 C2 DE 2656333C2
- Authority
- DE
- Germany
- Prior art keywords
- liposomes
- solution
- organ
- aqueous
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Description
33
Herstellung von Präparaten zur Beeinflussung des Sekretionsmechanismus und Auslösung von Insulinsekretion. Es werden dabei in Liposome Stoffe inkapsuliert, wie z. B. Zucker (Glukose, Mannose, Ribose), Hormone (STH, ACTH, Glukagon), Enterohormone (Sekretin, Pankreozymin, Sulfonylharnstoffe u. a.). Leucin, Arginin, Aminosäuregemische, Ketonkörper, Laurinsäure, Propionsäure, Buttersäure, Zitronensäure, Zyklisches AMP Xylit unter Zusatz von Extrakten aus Pankreas oder den B-Zellen desselben in einer Konzentration von μg bis ng pro ml. Andererseits kann die Insulinsekretion gehemmt werden durch Inkapsulierung von 2-Desoxyglukose, Mannoheptulose, Diazoxid, Adrenalin und Insulin. Beispielsweise geht man bei Verwendung von Glukose vop blutisotoner 5%iger Glukose aus. Die hergestellten Liposome werden von außen mit entsprechenden Extrakten des Pankreas oder B-Zellen imprägniert, bzw. wird als Suspensionsmittel eine wäßrige Lösung aus diesen Stoffen verwendet, wobei Natriumlaurylsulfat in μg- bis ng-Konzentrationen zugesetzt sein kann. In analoger Weise können durch Zufuhr von Induktoren oder Hemmstoffen auch andere Gewebearten und Zellen beeinflußt werden.Manufacture of preparations for influencing the secretion mechanism and triggering insulin secretion. There are thereby encapsulated substances in liposomes, such as. B. Sugar (glucose, mannose, ribose), hormones (STH, ACTH, glucagon), enteric hormones (secretin, pancreozymin, sulfonylureas, etc.). Leucine, arginine, Amino acid mixtures, ketone bodies, lauric acid, propionic acid, butyric acid, citric acid, cyclicals AMP xylitol with the addition of extracts from the pancreas or the B cells of the same in a concentration of μg to ng per ml. On the other hand, insulin secretion can be inhibited by encapsulating 2-deoxyglucose, Mannoheptulose, diazoxide, adrenaline, and insulin. For example, when using glucose, one starts from 5% glucose which is isotonic in blood. The manufactured Liposomes are impregnated from the outside with appropriate extracts from the pancreas or B cells, or an aqueous solution of these substances is used as the suspension medium, sodium lauryl sulfate be added in μg to ng concentrations can. In an analogous manner, other types of tissue can also be used by adding inducers or inhibitors and cells are affected.
3030th
3535
4040
5050
5555
6060
6565
Claims (1)
ehe Arzneistoffe enthalten, mit Zelltropisraus und 5 Besondere Anwendungsmöglichkeiten bestehen in verbesserter Permeabilität bei der Applikation, wo- der Auslösung und andererseits in der Hemmung spezibei aus Zeil- und Gewebeextrakten gewonnene bzw. Fischer Zellfunktionen, wie z. B. der Insulinsekretion und daraus isolierten Membranen Enzyme, zellspezifi- der Sekretion anderer Hormondrüsen durch die inkapsche Immunoglobuline oder spezifische Faktoren, sulierung von Induktionsstoffen bzw. Hemmstoffen ggf. die den Targetzellen entsprechen, an die Liposo- io in Kombination mit entsprechenden Zeil- bzw. Organmenmembran kovafcnt oder adsorptiv angekoppelt' extrakten und Imprägnierung der Liposomenmembran werden, nach Patent P 26 50502, dadurch ge- bzw. Verwendung analogerzytotroper Fraktionen auch kennzeichnet, daß die Lipoidmischung und die von Immunglobulinen im Suspensionsmittel (vgL Beiwäßrige Lösung mit einem Turbomischer homoge- spiel 2 und 3).
nisiert werden. 15Process for the production of liposomes, molecules contained in welfare pensions,
before containing drugs, with cell tropisraus and 5 special application possibilities consist in improved permeability during application, with triggering and, on the other hand, in the inhibition of specific cell and tissue extracts or Fischer cell functions, such as z. B. insulin secretion and membranes isolated from it, enzymes, cell-specific secretion of other hormonal glands by the encapsulated immunoglobulins or specific factors, sulphation of induction substances or inhibitors, if necessary, which correspond to the target cells, to the liposoio in combination with corresponding cell or Organmenmembrane covafcnt or adsorptively coupled 'extracts and impregnation of the liposome membrane are, according to patent P 26 50502, characterized or the use of analogous cytotropic fractions that the lipoid mixture and that of immunoglobulins in the suspension medium (see aqueous solution with a turbo mixer homogeneous game 2 and 3).
be nized. 15th
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19762656333 DE2656333C2 (en) | 1976-12-13 | 1976-12-13 | Process for the production of liposomes which contain medicinal substances |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19762656333 DE2656333C2 (en) | 1976-12-13 | 1976-12-13 | Process for the production of liposomes which contain medicinal substances |
Publications (2)
Publication Number | Publication Date |
---|---|
DE2656333A1 DE2656333A1 (en) | 1978-06-15 |
DE2656333C2 true DE2656333C2 (en) | 1985-08-08 |
Family
ID=5995363
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19762656333 Expired DE2656333C2 (en) | 1976-12-13 | 1976-12-13 | Process for the production of liposomes which contain medicinal substances |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE2656333C2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4263428A (en) * | 1978-03-24 | 1981-04-21 | The Regents Of The University Of California | Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same |
US4529561A (en) * | 1978-03-24 | 1985-07-16 | The Regents Of The University Of California | Method for producing liposomes in selected size range |
DE2964024D1 (en) * | 1978-10-02 | 1982-12-16 | Procter & Gamble | Liposomes for drug delivery and composition containing a liposome drug system |
US4377567A (en) | 1978-10-02 | 1983-03-22 | The Procter & Gamble Company | Lipid membrane drug delivery |
CA1173360A (en) * | 1979-06-22 | 1984-08-28 | Jurg Schrank | Pharmaceutical preparations |
US4310505A (en) * | 1979-11-08 | 1982-01-12 | California Institute Of Technology | Lipid vesicles bearing carbohydrate surfaces as lymphatic directed vehicles for therapeutic and diagnostic substances |
JPS60208910A (en) * | 1984-03-31 | 1985-10-21 | Green Cross Corp:The | Preparation of composite of hardly water-soluble drug and phospholipid |
IL79114A (en) * | 1985-08-07 | 1990-09-17 | Allergan Pharma | Method and composition for making liposomes |
-
1976
- 1976-12-13 DE DE19762656333 patent/DE2656333C2/en not_active Expired
Non-Patent Citations (1)
Title |
---|
NICHTS-ERMITTELT |
Also Published As
Publication number | Publication date |
---|---|
DE2656333A1 (en) | 1978-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0056781B1 (en) | Process for preparing liposomal drugs | |
KR890001882B1 (en) | Steroidal liposomes | |
US4897308A (en) | Compositions comprising aqueous dispersions of lipid spheres | |
DE19852928C1 (en) | Structures in the form of hollow spheres | |
EP0069307B1 (en) | Process for preparing liposome solutions | |
DE3689769T2 (en) | MULTILAMELLAR LIPOSOME WITH IMPROVED INCLUDING EFFECT. | |
EP0197987B2 (en) | Process for preparing a solution of inverted micellae | |
DE69018460T2 (en) | MARKING WITH LIPOSOMES FROM ISCHEMIC TISSUES. | |
JPH08208457A (en) | Preparation of sterol liposome | |
DE3335701A1 (en) | METHOD FOR PRODUCING LARGE MULTILAMELLAR LIPID BLADES | |
DE2907303A1 (en) | PROCESS FOR ENCAPSULATING BIOLOGICALLY ACTIVE SUBSTANCES | |
DE2747378A1 (en) | LIPOSOME, METHOD OF MANUFACTURING AND MEDICINAL PRODUCTS CONTAINING THEM | |
DE2655801A1 (en) | METHOD FOR PRODUCING A MASS OF LOADED CELLS SUSPENDED IN A PHYSIOLOGICAL SOLUTION | |
DE2656333C2 (en) | Process for the production of liposomes which contain medicinal substances | |
JPH0676340B2 (en) | Imiunosome and method for producing the same | |
US5556637A (en) | Water containing liposome system | |
DE2643641A1 (en) | ANTIGENT PREPARATIONS AND METHOD FOR THEIR MANUFACTURING | |
DE69122810T2 (en) | Liposomes | |
JPS6357508A (en) | Film-forming cosmetic pack | |
DE3433609A1 (en) | DEVELOPMENT OF THE METHOD FOR THE PRODUCTION OF DIET MILK AND CREAM | |
DE69838324T2 (en) | PH SENSITIVE LIPOSOMES AND OTHER TYPES OF IMMUNOMODULATORS OF CONTAINED VACCINES AND METHOD AND METHOD OF PREPARATION THEREOF | |
DE2650502B2 (en) | Production of liposomes which contain medicinal substances | |
CASLEY‐SMITH | Some observations on the electron microscopy of lipids | |
CA2048471C (en) | Water-containing liposome system | |
DE69904020T2 (en) | PHARMACEUTICAL COMPOSITION FOR THE NASAL ADMINISTRATION OF THIOCOLCHICOSIDE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8110 | Request for examination paragraph 44 | ||
AF | Is addition to no. |
Ref country code: DE Ref document number: 2650502 Format of ref document f/p: P |
|
D2 | Grant after examination | ||
8364 | No opposition during term of opposition |